Researchers to test blood cancer drug in COVID-19 patients
Scientists at Dana-Farber Cancer Institute have launched a clinical test of a blood cancer drug in patients infected with the COVID-19 virus. The test follows several case reports in which the drug, ibrutinib, appeared to ...
May 20, 2020
0
5